wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
MDV288
MDV288
http://dx.doi.org/10.1093/ANNONC/MDV288
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epi
P356
Q38543802-1EF66FE2-1AFE-4F9C-A2D5-D7E0FC4B859A
P356
MDV288
http://dx.doi.org/10.1093/ANNONC/MDV288